✦ LIBER ✦
Effect of EP4 agonist (ONO-4819CD) for patients with mild to moderate ulcerative colitis refractory to 5-aminosalicylates: A randomized phase II, placebo-controlled trial
✍ Scribed by Hiroshi Nakase; Yoshihide Fujiyama; Nobuhide Oshitani; Toru Oga; Kimiko Nonomura; Toshiyuki Matsuoka; Yoshiyasu Esaki; Toshinori Murayama; Satoshi Teramukai; Tsutomu Chiba; Shuh Narumiya
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 133 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1078-0998
No coin nor oath required. For personal study only.